Chronic Adverse Effects From Anti-PD-1 Immunotherapies Common
About 43 percent of patients who receive anti-PD1 therapy for advanced melanoma have chronic immune-related adverse effects
ATA Issues Guidelines for Managing Anaplastic Thyroid Cancer
Evidence-based guidelines address diagnosis, evaluation, and treatment, including early multidisciplinary care team involvement
Physician’s Briefing Weekly Coronavirus Roundup
U.S. Overdose Deaths Have Soared During COVID-19 Pandemic
Increase largely driven by illicitly manufactured fentanyl and other synthetic opioids
Thousands of Vaccinated People in U.S. Infected With COVID-19
New data are the first to indicate how effective COVID-19 vaccines are in real life
CDC Panel Says It Needs More Time to Study J&J Vaccine Clotting Cases
Advisers to the CDC say they do not have enough information or time to recommend how to proceed and they will meet again within 10 days
Psilocybin Compared With Escitalopram for Depression
No difference seen in change in depression scores at six weeks for psilocybin plus placebo versus psilocybin plus escitalopram
AAN: Race May Affect Response to Anti-CD20 Therapy for MS, NMOSD
B-cell repopulation occurs more often in African American versus White patients between six and 12 months after anti-CD20 infusion
Asthma Exacerbations, ED Admissions Decreased During Lockdown
Nonpharmaceutical interventions to reduce COVID-19 associated with reduction in admissions for COPD, asthma
CDC: U.S. STD Rate at Record High Again
In 2019, nearly 2.5 million Americans had an infection of chlamydia, gonorrhea, or syphilis
